The COVID-19 pandemic caused much illness, many deaths, and profound disruption to
society. The production of 'safe and effective'vaccines was a key public health target. Sadly …

Combining existing drug therapy is essential in developing new therapeutic agents in
disease prevention and treatment. In preclinical investigations, combined effect of certain …

Myocarditis as cardiac involvement in coronavirus disease 2019 (COVID‐19)‐infection is
well known. Real‐world data about incidence in hospitalized COVID‐19‐patients and risk …

Background An exuberant and dysregulated inflammatory response contributes to the
development and progression of cardiovascular diseases (CVDs). Methods This narrative …

SARS-CoV-2 vaccine–associated myocarditis/myocardial injury should be evaluated in the
contexts of COVID-19 infection, other types of viral myocarditis, and other vaccine …

The clinical manifestations of the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection responsible for coronavirus disease 2019 (COVID-19) commonly include …

Background Acute myocarditis is an inflammation of the myocardium that can cause life-
threatening events. However, anti-inflammatory strategies did not reduce the risk of clinical …

Myocarditis is an inflammatory cardiac disease characterized by the destruction of
myocardial cells, infiltration of interstitial inflammatory cells, and fibrosis, and is becoming a …

Traditional cardiomyopathy paradigms segregate inflammatory etiologies from those caused
by genetic variants. An identified or presumed trigger is implicated in acute myocarditis or …

Myocarditis is an inflammatory heart disease that leads to loss of cardiomyocytes and
frequently precipitates fibrotic remodeling of the myocardium, culminating in heart failure …